United Therapeutics (UTHR) Raw Materials (2010 - 2020)

United Therapeutics (UTHR) has 11 years of Raw Materials data on file, last reported at $20.1 million in Q1 2020.

• For the quarter ending Q1 2020, Raw Materials fell 9.87% year-over-year to $20.1 million; the trailing twelve-month figure through Mar 2020 stood at $20.1 million (down 9.87% YoY), and the FY2019 full-year result was $21.1 million, down 13.17% from the prior year.
• Raw Materials eased to $20.1 million in Q1 2020, from $21.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $29.1 million in Q2 2017 to a low of $19.3 million in Q3 2019.
• A 5-year average of $24.4 million and a median of $24.8 million in 2016 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials climbed 17.34% in 2017 and declined 25.77% in 2019, its largest moves.
• Tracing UTHR's Raw Materials over 5 years: stood at $25.4 million in 2016, then grew by 9.84% to $27.9 million in 2017, then declined by 12.9% to $24.3 million in 2018, then decreased by 13.17% to $21.1 million in 2019, then fell by 4.74% to $20.1 million in 2020.
• Business Quant data shows UTHR's Raw Materials at $20.1 million in Q1 2020, $21.1 million in Q4 2019, and $19.3 million in Q3 2019.